Shamsuddin Virani

630 total citations
8 papers, 131 citations indexed

About

Shamsuddin Virani is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Shamsuddin Virani has authored 8 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Shamsuddin Virani's work include Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Shamsuddin Virani is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Shamsuddin Virani collaborates with scholars based in United States. Shamsuddin Virani's co-authors include Scot C. Remick, Jame Abraham, Mary W. Redman, Elizabeth Garrett‐Mayer, Bruce E. Johnson, Caroline Schenkel, Janet Freeman‐Daily, Robert A. Smith, Kathryn F. Mileham and Lauren Rosenthal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Shamsuddin Virani

8 papers receiving 126 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shamsuddin Virani United States 5 51 49 44 38 35 8 131
Vida Almario Passero United States 7 50 1.0× 78 1.6× 32 0.7× 38 1.0× 27 0.8× 24 228
Nathanaël Charrier France 5 25 0.5× 25 0.5× 25 0.6× 17 0.4× 37 1.1× 5 117
Gabriela Sousa Portugal 8 19 0.4× 71 1.4× 36 0.8× 32 0.8× 32 0.9× 35 163
Miriam O’Connor Ireland 7 20 0.4× 44 0.9× 23 0.5× 24 0.6× 37 1.1× 19 117
Stephen Della‐Fiorentina Australia 9 54 1.1× 119 2.4× 39 0.9× 21 0.6× 38 1.1× 24 190
Steven Latosinsky Canada 7 29 0.6× 60 1.2× 17 0.4× 39 1.0× 35 1.0× 10 173
Brittney S. Zimmerman United States 7 41 0.8× 93 1.9× 27 0.6× 14 0.4× 15 0.4× 16 141
Yvonne van Riet Netherlands 4 53 1.0× 153 3.1× 32 0.7× 16 0.4× 70 2.0× 5 218
Aneta Suder United Kingdom 5 29 0.6× 51 1.0× 22 0.5× 27 0.7× 20 0.6× 13 116
Ana Molina‐Barceló Spain 9 39 0.8× 156 3.2× 29 0.7× 19 0.5× 14 0.4× 37 243

Countries citing papers authored by Shamsuddin Virani

Since Specialization
Citations

This map shows the geographic impact of Shamsuddin Virani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shamsuddin Virani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shamsuddin Virani more than expected).

Fields of papers citing papers by Shamsuddin Virani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shamsuddin Virani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shamsuddin Virani. The network helps show where Shamsuddin Virani may publish in the future.

Co-authorship network of co-authors of Shamsuddin Virani

This figure shows the co-authorship network connecting the top 25 collaborators of Shamsuddin Virani. A scholar is included among the top collaborators of Shamsuddin Virani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shamsuddin Virani. Shamsuddin Virani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ballinger, Tarah J., Fengmin Zhao, Joseph A. Sparano, et al.. (2024). ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer.. Journal of Clinical Oncology. 42(17_suppl). LBA503–LBA503. 1 indexed citations
2.
Mileham, Kathryn F., Caroline Schenkel, Suanna S. Bruinooge, et al.. (2021). Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists. Cancer Medicine. 11(2). 530–538. 38 indexed citations
3.
Bradbury, Angela R., Ju‐Whei Lee, Jill B. Gaieski, et al.. (2021). A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152). Cancer. 128(7). 1381–1391. 7 indexed citations
4.
Mileham, Kathryn F., Upal Kunal Basu Roy, Suanna S. Bruinooge, et al.. (2021). Physician concern about delaying lung cancer treatment while awaiting biomarker testing: Results of a survey of U.S. oncologists.. Journal of Clinical Oncology. 39(15_suppl). 9067–9067. 2 indexed citations
5.
Thompson, Michael A., Michael P. Mullane, Amanda M. Wilson, et al.. (2019). Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One. SHILAP Revista de lepidopterología. 6(1). 36–45. 6 indexed citations
6.
Oh, Young S., et al.. (2013). Lack of Impact on Polyp Detection by Fellow Involvement During Colonoscopy: A Meta-Analysis. Digestive Diseases and Sciences. 58(12). 3413–3421. 13 indexed citations
7.
Virani, Shamsuddin, et al.. (2011). Barriers to Recruitment of Rural Patients in Cancer Clinical Trials. Journal of Oncology Practice. 7(3). 172–177. 60 indexed citations
8.
Virani, Shamsuddin, et al.. (2009). Transverse myelitis: amphiphysin autoimmunity paraneoplastic syndrome in a woman with breast cancer.. PubMed. 7(3). 180–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026